REKEMEND Trademark

Trademark Overview


On Tuesday, March 23, 2021, a trademark application was filed for REKEMEND with the United States Patent and Trademark Office. The USPTO has given the REKEMEND trademark a serial number of 90596028. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Thursday, August 1, 2024. This trademark is owned by 1295286 B.C. LTD.. The REKEMEND trademark is filed in the Pharmaceutical Products category with the following description:

Appetite suppressant pills; Appetite suppressants; Appetite suppressants for medical purposes; Fungal extracts sold as a component ingredient of nutritional supplements and vitamins; Fungal medications; Nutraceuticals for use as a dietary supplement; Pharmaceutical preparations for the treatment of hypercholesteremia; Pharmaceutical preparations for the treatment of hyperlipidemia; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical skin lotions; Pharmaceuticals, namely, lipid lowering agents; Pharmaceuticals, namely, psychotropics; Balms for pharmaceutical purposes; Dietary supplement beverage for supporting immunity, enhancing mood and well-being, and suppressing appetite; Dietary supplement drink mix...
rekemend

General Information


Serial Number90596028
Word MarkREKEMEND
Filing DateTuesday, March 23, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateThursday, August 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 7, 2021

Trademark Statements


Goods and ServicesAppetite suppressant pills; Appetite suppressants; Appetite suppressants for medical purposes; Fungal extracts sold as a component ingredient of nutritional supplements and vitamins; Fungal medications; Nutraceuticals for use as a dietary supplement; Pharmaceutical preparations for the treatment of hypercholesteremia; Pharmaceutical preparations for the treatment of hyperlipidemia; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical skin lotions; Pharmaceuticals, namely, lipid lowering agents; Pharmaceuticals, namely, psychotropics; Balms for pharmaceutical purposes; Dietary supplement beverage for supporting immunity, enhancing mood and well-being, and suppressing appetite; Dietary supplement drink mixes; Dietary supplements; Dietary supplements also containing adaptogens, nootropics, mushrooms and mushroom extracts; Dietary supplements consisting primarily of adaptogens, nootropics, mushrooms and mushroom extracts; Dietary supplements for controlling cholesterol; Dietary supplements for human consumption; Dietary and nutritional supplements; Dietary and nutritional supplements containing adaptogens, nootropics, mushrooms and mushroom extracts; Dietary and nutritional supplements for endurance sports; Dietary and nutritional supplements for supporting immunity, enhancing mood and well-being, and suppressing appetite; Dietary and nutritional supplements used for weight loss; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Dietary food supplements; Dietary supplements in the nature of weight loss powders; Dietetic preparations adapted for medical purposes; Flour for pharmaceutical purposes; Food supplements; Health food supplements; Homeopathic supplements; Liquid nutritional supplement; Natural supplements for treating depression and anxiety; Natural dietary supplements; Nutraceuticals for use as a dietary supplement for supporting immunity, enhancing mood and well-being, and suppressing appetite; Nutritional supplement shakes; Nutritional supplements; Nutritional supplements consisting primarily of adaptogens, nootropics, mushrooms and mushroom extracts; Pharmaceutical preparations, namely, appetite suppressants; Powdered nutritional supplement concentrate; Powdered nutritional supplement drink mix; Powdered nutritional supplement drink mix and concentrate; Therapeutic agents for weight control and appetite suppression; Weight management supplements

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, June 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameREKEMEND LLC
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressHOLLYWOOD, FL 33019

Party Name1295286 B.C. LTD.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressToronto M5A1N1
CA

Party Name1295286 B.C. LTD.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressToronto M5A1N1
CA

Trademark Events


Event DateEvent Description
Friday, March 26, 2021NEW APPLICATION ENTERED
Saturday, June 26, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 29, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 28, 2021ASSIGNED TO EXAMINER
Wednesday, November 17, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 7, 2021PUBLISHED FOR OPPOSITION
Tuesday, December 7, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, August 1, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, January 12, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, February 1, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, August 1, 2022SOU EXTENSION 1 FILED
Monday, August 1, 2022SOU EXTENSION 1 GRANTED
Wednesday, February 1, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, August 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 1, 2023SOU EXTENSION 2 FILED
Wednesday, February 1, 2023SOU EXTENSION 2 GRANTED
Thursday, August 3, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 1, 2024SOU EXTENSION 4 GRANTED
Friday, February 3, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 1, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, August 1, 2023SOU EXTENSION 3 FILED
Tuesday, August 1, 2023SOU EXTENSION 3 GRANTED
Thursday, February 1, 2024SOU TEAS EXTENSION RECEIVED
Thursday, February 1, 2024SOU EXTENSION 4 FILED
Monday, February 3, 2025TEAS STATEMENT OF USE RECEIVED
Thursday, August 1, 2024SOU EXTENSION 5 FILED
Saturday, February 3, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 1, 2024SOU TEAS EXTENSION RECEIVED
Thursday, August 1, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 1, 2024SOU EXTENSION 5 GRANTED